TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3034% below fair value
$85.25−8.77 (-9.33%)
Close on Nov 20, 2026Market cap $2.96BP/E 22.1Yield 0.00%
TransMedics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
TransMedics's gross profit for the twelve months ending Jun 30, 2026 was $392.35M, up 23.5% year over year. For fiscal 2025 it was $362.81M, up 38.4% from the year before. The highest annual figure on record is $362.81M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $362.81M | +38.4% |
| FY2024 | Dec 31, 2024 | $262.08M | +70.1% |
| FY2023 | Dec 31, 2023 | $154.09M | +136.1% |
| FY2022 | Dec 31, 2022 | $65.27M | +208.5% |
| FY2021 | Dec 31, 2021 | $21.16M | +27.2% |
| FY2020 | Dec 31, 2020 | $16.64M | +20.0% |
| FY2019 | Dec 28, 2019 | $13.86M | +141.8% |
| FY2018 | Dec 29, 2018 | $5.73M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $113.20M | +17.2% |
| Q1 FY2026 | Mar 31, 2026 | $101.16M | +14.7% |
| Q4 FY2025 | Dec 31, 2025 | $93.41M | +29.7% |
| Q3 FY2025 | Sep 30, 2025 | $84.58M | +39.0% |
| Q2 FY2025 | Jun 30, 2025 | $96.59M | +39.5% |
| Q1 FY2025 | Mar 31, 2025 | $88.23M | +47.1% |
| Q4 FY2024 | Dec 31, 2024 | $72.01M | +50.3% |
| Q3 FY2024 | Sep 30, 2024 | $60.85M | +49.6% |
| Q2 FY2024 | Jun 30, 2024 | $69.26M | +88.5% |
| Q1 FY2024 | Mar 31, 2024 | $59.96M | +108.4% |
| Q4 FY2023 | Dec 31, 2023 | $47.92M | +131.5% |
| Q3 FY2023 | Sep 30, 2023 | $40.66M | +124.5% |
| Q2 FY2023 | Jun 30, 2023 | $36.74M | +156.0% |
| Q1 FY2023 | Mar 31, 2023 | $28.77M | +137.7% |
| Q4 FY2022 | Dec 31, 2022 | $20.70M | +196.3% |
| Q3 FY2022 | Sep 30, 2022 | $18.12M | +380.1% |
| Q2 FY2022 | Jun 30, 2022 | $14.35M | +156.8% |
| Q1 FY2022 | Mar 31, 2022 | $12.10M | +151.6% |
| Q4 FY2021 | Dec 31, 2021 | $6.99M | +44.7% |
| Q3 FY2021 | Sep 30, 2021 | $3.77M | -25.1% |
| Q2 FY2021 | Jun 30, 2021 | $5.59M | +192.8% |
| Q1 FY2021 | Mar 31, 2021 | $4.81M | -1.0% |
| Q4 FY2020 | Dec 31, 2020 | $4.83M | +29.1% |
| Q3 FY2020 | Sep 30, 2020 | $5.04M | +19.5% |
| Q2 FY2020 | Jun 30, 2020 | $1.91M | -42.7% |
| Q1 FY2020 | Mar 31, 2020 | $4.86M | +88.9% |
| Q4 FY2019 | Dec 28, 2019 | $3.74M | +149.6% |
| Q3 FY2019 | Sep 28, 2019 | $4.22M | +97.7% |
| Q2 FY2019 | Jun 29, 2019 | $3.33M | +182.7% |
| Q1 FY2019 | Mar 30, 2019 | $2.57M | +178.5% |
| Q4 FY2018 | Dec 29, 2018 | $1.50M | – |
| Q3 FY2018 | Sep 29, 2018 | $2.13M | – |
| Q2 FY2018 | Jun 30, 2018 | $1.18M | – |
| Q1 FY2018 | Mar 31, 2018 | $924.00K | – |
See a number that looks wrong?